CORVUS PHARMACEUTICALS INC's ticker is CRVS and the CUSIP is 221015100. A total of 39 filers reported holding CORVUS PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $73,000 | -91.6% | 34,709 | -78.3% | 0.01% | -58.3% |
| Q4 2019 | $869,000 | +133.6% | 159,773 | +29.2% | 0.02% | +166.7% |
| Q3 2019 | $372,000 | +5.1% | 123,709 | +30.6% | 0.01% | +12.5% |
| Q2 2019 | $354,000 | 0.0% | 94,696 | +7.6% | 0.01% | 0.0% |
| Q1 2019 | $354,000 | +4.1% | 88,033 | -4.9% | 0.01% | -11.1% |
| Q4 2018 | $340,000 | -38.2% | 92,601 | +44.8% | 0.01% | -18.2% |
| Q3 2018 | $550,000 | -9.4% | 63,936 | +16.2% | 0.01% | -8.3% |
| Q2 2018 | $607,000 | -1.3% | 55,034 | +3.2% | 0.01% | -7.7% |
| Q1 2018 | $615,000 | +140.2% | 53,352 | +123.9% | 0.01% | +116.7% |
| Q4 2017 | $256,000 | -10.8% | 23,829 | +72.6% | 0.01% | -14.3% |
| Q1 2017 | $287,000 | – | 13,809 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 3,101,709 | $7,475,000 | 1.50% |
| ADAMS STREET PARTNERS LLC | 3,275,616 | $7,894,000 | 1.20% |
| Telemetry Investments, L.L.C. | 192,909 | $465,000 | 0.60% |
| CHI Advisors LLC | 400,000 | $964,000 | 0.32% |
| Orbimed Advisors | 6,943,654 | $16,734,000 | 0.22% |
| Ikarian Capital, LLC | 482,610 | $1,163,000 | 0.17% |
| Anson Funds Management LP | 528,358 | $1,273,000 | 0.12% |
| BVF INC/IL | 1,370,947 | $3,304,000 | 0.12% |
| VR Adviser, LLC | 250,000 | $603,000 | 0.08% |
| PURA VIDA INVESTMENTS, LLC | 492,384 | $1,187,000 | 0.04% |